Latest 10-K annual reports
NYSE
Getty Images reports a significant net loss in 2025, driven by substantial litigation and merger-related costs, despite overall revenue growth and strategic debt management.
NYSE
FutureFuel Corp. reported a significant 61% revenue drop and a net loss in 2025, primarily due to regulatory uncertainty in its Biofuels segment and operational challenges in Chemicals.
AMEX
The Arena Group Holdings, Inc. reported a significant turnaround in 2025, achieving net income from continuing operations of $28.6 million and a working capital surplus, driven by increased digital revenue and reduced operating costs.
NYSE
Babcock & Wilcox Enterprises, Inc. significantly improved its financial performance in 2025, reducing net losses and securing a major $2.4 billion natural gas power plant project, while addressing prior going concern doubts.
NASDAQ
Eagle Financial Services reports a strategic 2025, marked by a successful capital raise and investment portfolio repositioning, despite a GAAP net income decline driven by one-time losses.
Zomedica Corp. reported a 17% increase in revenue to $32.03 million for fiscal year 2025, alongside a significant net loss of $81.86 million driven by impairment charges following its delisting from NYSE American.
NASDAQ
BMBL
Bumble INCBumble Inc. recorded an $895.3 million net loss in 2025, driven by substantial impairment charges and a strategic pivot that impacted user growth, while securing a new $475 million term loan for debt refinancing.
NASDAQ
Hudson Technologies saw revenue growth in 2025 driven by higher sales volumes, but net income declined due to lower selling prices, increased freight costs, and higher operating expenses, while navigating a key DLA contract protest.
NASDAQ
TLS
Telos CORPTelos Corporation announced a 52.2% revenue increase and a significant shift to positive cash flow from operations for fiscal year 2025, driven by its Security Solutions segment, despite a goodwill impairment in Secure Networks.
NYSE
Natural Gas Services Group, Inc. (NGS) reported a significant increase in rental revenue and net income for the fiscal year ended December 31, 2025, driven by expanded large horsepower fleet utilization and strategic capital deployment.
NYSE
EVEX
Eve Holding, INCEve Holding, a developer of Urban Air Mobility solutions, reported significantly increased net losses in 2025 despite achieving its eVTOL prototype's first flight and securing substantial new financing.
NASDAQ
Cue Biopharma reports recurring losses and going concern doubt, while advancing its autoimmune pipeline with CUE-401 nearing IND filing and CUE-501 licensed to Boehringer Ingelheim, alongside oncology asset licensing.
NASDAQ
TrustCo Bank Corp NY announced a significant increase in net income and earnings per share for 2025, alongside robust loan and deposit growth and an expanded share repurchase program.
NYSE
USANA Health Sciences, Inc. reported a significant 74.4% decrease in net earnings for fiscal year 2025, despite an 8.3% increase in net sales driven by the Hiya acquisition, as its core nutritional business experienced a 14.8% decline in active customers.
NASDAQ
Full House Resorts saw a 3.5% revenue increase in 2025, driven by its new American Place and Chamonix casinos, despite a slight dip in Adjusted EBITDA and continued net losses.
NASDAQ
Kingstone Companies achieved a 122% surge in net income for 2025, driven by strong premium growth and improved underwriting, while also announcing ambitious expansion plans into new states.
NASDAQ
Security National Financial Corporation reports a 3.0% increase in total revenues and a 10.4% rise in net earnings for 2025, despite an identified material weakness in internal controls.
NYSE
W&T Offshore's 2025 annual report highlights a strategic debt refinancing, increased natural gas production, and ongoing legal battles over decommissioning liabilities amidst fluctuating commodity prices.
NASDAQ
Orange County Bancorp, Inc. announced significant financial growth in 2025, with net income up 49.2% to $41.6 million and total assets reaching $2.7 billion.
OQB
Magnolia Bancorp, Inc. reported a net loss for the year ended December 31, 2025, as increased public company expenses offset growth in net interest income following its January 2025 conversion to a stock form and IPO.
NASDAQ
Science Applications International Corporation (SAIC) reported a 3% revenue decrease in fiscal 2026, driven by contract completions and a government shutdown, alongside strategic reorganizations and an acquisition.
AMEX
Healthy Choice Wellness Corp. (HCWC) reported a narrower net loss and increased cash for fiscal year 2025, driven by acquisitions and operational improvements, despite an increased working capital deficit and identified internal control weaknesses.
NASDAQ
FVCB
Fvcbankcorp, INCFVCBankcorp announced a 46% surge in net income for 2025, driven by increased net interest income and strategic growth initiatives, while maintaining robust capital levels.
OQX
QNBC
Qnb CORPQNB Corp. announced a significant increase in net income for 2025, driven by improved net interest income and margin, while progressing with its merger with The Victory Bancorp, Inc.
NASDAQ
FTAI Infrastructure Inc. reported a significant increase in total revenues for the year ended December 31, 2025, driven by acquisitions and growth in its Power and Gas and Jefferson Terminal segments, despite a net loss.
NYSE
Stoneridge, Inc. reported a significant net loss of $102.8 million for fiscal year 2025, alongside a strategic divestiture of its Control Devices segment in January 2026 to focus on high-growth electronics and Brazil markets.
NASDAQ
Peoples Financial Services Corp. announced a significant increase in net income for 2025, driven by a full year of FNCB merger operations and reduced credit loss provisions, alongside improved asset quality and capital ratios.
NASDAQ
Aprea Therapeutics, a clinical-stage precision oncology company, reported a net loss of $12.6 million for 2025 and warned of substantial doubt about its ability to continue as a going concern, alongside a Nasdaq minimum bid price deficiency.
NASDAQ
D. Boral ARC Acquisition I Corp., a SPAC, announced a definitive merger agreement with Exascale Labs Inc. valued at $500 million, while auditors express going concern doubt.
NASDAQ
Lifecore Biomedical, Inc. reports significant revenue and cash flow improvements for its transition period, despite ongoing net losses and internal control weaknesses.